Article
Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.
The Journal of clinical investigation - 1 Jan 2016
Suzuki Motoshi, Cao Ke, Kato Seiichi, Komizu Yuji, Mizutani Naoki, Tanaka Kouji, Arima Chinatsu, Tai Mei Chee, Yanagisawa Kiyoshi, Togawa Norie, Shiraishi Takahiro, Usami Noriyasu, Taniguchi Tetsuo, Fukui Takayuki, Yokoi Kohei, Wakahara Keiko, Hasegawa Yoshinori, Mizutani Yukiko, Igarashi Yasuyuki, Inokuchi Jin-ichi, Iwaki Soichiro, Fujii Satoshi, Satou Akira, Matsumoto Yoko, Ueoka Ryuichi, Tamiya-Koizumi Keiko, Murate Takashi, Nakamura Mitsuhiro, Kyogashima Mamoru, Takahashi Takashi
Abstract excerpt
Sphingolipids make up a family of molecules associated with an array of biological functions, including cell death and migration. Sphingolipids are often altered in cancer, though how these alterations lead to tumor formation and progression is largely unknown. Here, we analyzed non-small-cell lung cancer (NSCLC) specimens and cell lines and determined that ceramide synthase 6 (CERS6) is markedly overexpressed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
